 | Arcus Biosciences, Inc. | |||
| NYQ : RCUS || Location: United States | ||||
$15.55+0.82 (+5.57%) |
0.49 M | 14.59 - 15.61 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 6.843 M |
| March 28, 2024 | 8.253 M |
| March 15, 2024 | 7.984 M |
| Feb. 29, 2024 | 7.683 M |
| Feb. 15, 2024 | 7.525 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.04 | -1.08 | -3.39% |
| 09/30/2023 | -1.15 | -0.94 | 18.35% |
| 06/30/2023 | -1.12 | -1.04 | 7.18% |
| 03/31/2023 | -1.19 | -1.09 | 8.13% |
| 12/31/2022 | -1.09 | -0.93 | 14.54% |
RCUS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 90.953M | Shares Float | 54.391M |
| Short Float | 6.843M | Market Cap | 1339.74M |
| Institution ownership | 59.78% | Insider ownership | 41.134% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.15 | Forward EPS | -4.24 |